Tae-Ho Hwang

4.6k total citations · 1 hit paper
70 papers, 3.6k citations indexed

About

Tae-Ho Hwang is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Tae-Ho Hwang has authored 70 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 31 papers in Genetics and 20 papers in Oncology. Recurrent topics in Tae-Ho Hwang's work include Virus-based gene therapy research (30 papers), CAR-T cell therapy research (16 papers) and Viral Infectious Diseases and Gene Expression in Insects (14 papers). Tae-Ho Hwang is often cited by papers focused on Virus-based gene therapy research (30 papers), CAR-T cell therapy research (16 papers) and Viral Infectious Diseases and Gene Expression in Insects (14 papers). Tae-Ho Hwang collaborates with scholars based in South Korea, United States and Canada. Tae-Ho Hwang's co-authors include David H. Kirn, John C. Bell, Caroline J. Breitbach, Anne Moon, Ta‐Chiang Liu, Lawrence Chan, Millan S. Patel, Benny Hung‐Junn Chang, Richard A. Lang and Lan Li and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Tae-Ho Hwang

67 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor

2002 863 citations Tae-Ho Hwang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tae-Ho Hwang South Korea	21	2.0k	1.7k	1.6k	589	458	70	3.6k
Yaohe Wang United Kingdom	36	2.4k 1.2×	2.0k 1.2×	2.1k 1.3×	792 1.3×	702 1.5×	130	4.3k
Xiaoliu Zhang United States	28	991 0.5×	924 0.5×	978 0.6×	526 0.9×	119 0.3×	103	2.4k
Dong Sung An United States	35	1.2k 0.6×	2.8k 1.7×	632 0.4×	1.3k 2.2×	68 0.1×	78	4.8k
Karin Jooss United States	37	2.5k 1.3×	3.2k 1.9×	2.4k 1.5×	1.7k 2.9×	259 0.6×	74	5.8k
Brian Champion United Kingdom	28	658 0.3×	987 0.6×	730 0.5×	1.0k 1.8×	158 0.3×	90	2.8k
Yeou‐Ping Tsao Taiwan	33	825 0.4×	2.0k 1.2×	578 0.4×	546 0.9×	61 0.1×	117	3.5k
Paul E. Monahan United States	36	2.3k 1.2×	2.3k 1.4×	887 0.5×	184 0.3×	44 0.1×	99	4.2k
Lisa Burzenski United States	22	628 0.3×	925 0.5×	923 0.6×	1.4k 2.4×	172 0.4×	41	3.1k
Richard G. Carroll United States	45	1.5k 0.8×	2.5k 1.5×	3.5k 2.2×	3.4k 5.8×	215 0.5×	68	7.6k
Dwight A. Bellinger United States	35	2.6k 1.3×	2.4k 1.4×	1.2k 0.7×	349 0.6×	52 0.1×	81	4.7k

Countries citing papers authored by Tae-Ho Hwang

Since Specialization

Citations

This map shows the geographic impact of Tae-Ho Hwang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tae-Ho Hwang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tae-Ho Hwang more than expected).

Fields of papers citing papers by Tae-Ho Hwang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tae-Ho Hwang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tae-Ho Hwang. The network helps show where Tae-Ho Hwang may publish in the future.

Co-authorship network of co-authors of Tae-Ho Hwang

This figure shows the co-authorship network connecting the top 25 collaborators of Tae-Ho Hwang. A scholar is included among the top collaborators of Tae-Ho Hwang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tae-Ho Hwang. Tae-Ho Hwang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kim, Jae-Joon, et al.. (2024). Dose Considerations for Vaccinia Oncolytic Virus Based on Retrospective Reanalysis of Early and Late Clinical Trials. Vaccines. 12(9). 1010–1010. 7 indexed citations

Kim, Kyeong-Ae, et al.. (2023). Immunotherapy for Peritoneal Carcinomatosis: Challenges and Prospective Outcomes. Cancers. 15(8). 2383–2383. 18 indexed citations

Kim, Sunwoo, et al.. (2023). Datasets, tasks, and training methods for large-scale hypergraph learning. Data Mining and Knowledge Discovery. 37(6). 2216–2254. 7 indexed citations

Hong, Wooyoung, et al.. (2022). Use of combined treatment of 3rd-generation cephalosporin, azithromycin and antiviral agents on moderate SARs-CoV-2 patients in South Korea: A retrospective cohort study. PLoS ONE. 17(5). e0267645–e0267645. 3 indexed citations

Jiang, Fen, et al.. (2019). Characterization of Oncolytic Vaccinia Virus Harboring the Human IFNB1 and CES2 Transgenes. Cancer Research and Treatment. 52(1). 309–319. 5 indexed citations

Jiang, Fen, Ung Bae Jeon, Mong Cho, et al.. (2018). Preclinical safety evaluation of hepatic arterial infusion of oncolytic poxvirus. Drug Design Development and Therapy. Volume 12. 2467–2474. 8 indexed citations

Breitbach, Caroline J., John C. Bell, Tae-Ho Hwang, David H. Kirn, & James M. Burke. (2015). The emerging therapeutic potential of the oncolytic immunotherapeutic Pexa-Vec (JX-594). PubMed. 4. 25–25. 46 indexed citations

Breitbach, Caroline J., Kelley A. Parato, James M. Burke, et al.. (2015). Pexa-Vec double agent engineered vaccinia: oncolytic and active immunotherapeutic. Current Opinion in Virology. 13. 49–54. 39 indexed citations

Breitbach, Caroline J., Rozanne Arulanandam, Naomi De Silva, et al.. (2013). Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans. Cancer Research. 73(4). 1265–1275. 208 indexed citations

10.

Noh, Kyung Tae, Young-Il Jeong, In Duk Jung, et al.. (2013). Rhamnogalacturonan II is a Toll-like receptor 4 agonist that inhibits tumor growth by activating dendritic cell-mediated CD8+ T cells. Experimental & Molecular Medicine. 45(2). e8–e8. 26 indexed citations

11.

Hwang, Tae-Ho, Anne Moon, James M. Burke, et al.. (2011). A Mechanistic Proof-of-concept Clinical Trial With JX-594, a Targeted Multi-mechanistic Oncolytic Poxvirus, in Patients With Metastatic Melanoma. Molecular Therapy. 19(10). 1913–1922. 122 indexed citations

12.

Parato, Kelley A., Caroline J. Breitbach, Fabrice Le Bœuf, et al.. (2011). The Oncolytic Poxvirus JX-594 Selectively Replicates in and Destroys Cancer Cells Driven by Genetic Pathways Commonly Activated in Cancers. Molecular Therapy. 20(4). 749–758. 224 indexed citations

13.

Hwang, Tae-Ho, et al.. (2010). CLIC: clustering analysis of large microarray datasets with individual dimension-based clustering. Nucleic Acids Research. 38(suppl_2). W246–W253. 10 indexed citations

14.

Liu, Ta‐Chiang, et al.. (2008). The Targeted Oncolytic Poxvirus JX-594 Demonstrates Antitumoral, Antivascular, and Anti-HBV Activities in Patients With Hepatocellular Carcinoma. Molecular Therapy. 16(9). 1637–1642. 161 indexed citations

15.

Hwang, Tae-Ho, Hyuk-Chan Kwon, Kelly Speth, et al.. (2007). A phase I-II clinical trial with JX-594, a targeted and GM-CSF-armed oncolytic poxvirus, by intratumoral injection in patients with liver tumors. Molecular Cancer Therapeutics. 6. 5 indexed citations

16.

Roh, Mee-Sook, et al.. (2006). Systemic Armed Oncolytic and Immunologic Therapy for Cancer with JX-594, a Targeted Poxvirus Expressing GM-CSF. Molecular Therapy. 14(3). 361–370. 235 indexed citations

17.

Lee, Jinhwa, Jin‐Sook Jeong, Seo-Hee Rha, et al.. (2004). Vascular administration of adenoviral vector soaked in absorbable gelatin sponge particles (GSP) prolongs the transgene expression in hepatocytes. Cancer Gene Therapy. 12(2). 116–121. 7 indexed citations

18.

Hong, Sook Hee, et al.. (2002). Fenofibrate lowers abdominal and skeletal adiposity and improves insulin sensitivity in OLETF rats. Biochemical and Biophysical Research Communications. 296(2). 293–299. 96 indexed citations

19.

Jeong, Jin‐Sook, et al.. (2002). Ultrasonographic Evidence of Phenotypic Instability during Hepatocarcinogenesis in N-Nitrosomorpholine-Treated Rats. Experimental and Molecular Pathology. 73(1). 67–73. 6 indexed citations

20.

Jeong, Jin‐Sook, Hye‐Jeong Lee, Sanghoon Shin, et al.. (2001). Characterization of Inwardly Rectifying K+ Conductance across the Basolateral Membrane of Rat Tracheal Epithelia. Biochemical and Biophysical Research Communications. 288(4). 914–920. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact